Description
Halaven 0.44 mg/ml Injection – Advanced Chemotherapy for Metastatic Cancer
Halaven 0.44 mg/ml Injection is a specialized chemotherapy medication used in the treatment of advanced or metastatic cancers, particularly breast cancer and certain types of soft tissue sarcoma. It contains Eribulin Mesylate, a microtubule dynamics inhibitor that works by interfering with cancer cell division, ultimately leading to cancer cell death.
By slowing tumor growth and preventing cancer cells from multiplying, Halaven helps improve treatment outcomes in patients with previously treated metastatic cancers.
📋 Product Profile
- Active Component: Eribulin Mesylate
- Strength: 0.44 mg/ml
- Therapeutic Class: Antineoplastic / Microtubule Inhibitor (Chemotherapy)
- Indications: Metastatic Breast Cancer & Certain Soft Tissue Sarcomas (e.g., liposarcoma)
- Dosage Form: Injectable Solution (Intravenous Use)
🎯 Primary Indications
Halaven Injection is commonly prescribed for:
- Metastatic Breast Cancer:
Used in patients whose cancer has spread to other parts of the body after prior chemotherapy treatments. - Advanced Soft Tissue Sarcoma:
Effective in certain types such as liposarcoma, particularly after previous therapy failure. - Cancer Progression Control:
Helps slow tumor growth and may improve overall survival in advanced cancer stages. - Post-Chemotherapy Treatment:
Typically prescribed after other chemotherapy regimens have been attempted.
⚙️ Mechanism of Action
Halaven works by disrupting cancer cell division:
- Microtubule Inhibition:
Eribulin inhibits microtubule growth required for cell division. - Mitotic Blockade:
Prevents cancer cells from completing the mitosis process. - Cancer Cell Death:
This disruption leads to apoptosis (programmed cancer cell death). - Tumor Growth Suppression:
Ultimately slows tumor growth and spread.
💊 Administration & Dosage
- Professional Administration:
Must be administered by a qualified healthcare professional in a hospital or oncology clinic. - Route:
Intravenous (IV) injection - Typical Regimen:
Usually administered on Day 1 and Day 8 of a 21-day cycle, as per the oncologist’s protocol - Monitoring:
Blood tests (especially complete blood counts) and clinical monitoring are required before and during treatment
⚠️ Safety & Precautions
| Feature | Guideline |
|---|---|
| Blood Cell Counts | Regular monitoring required due to risk of neutropenia |
| Liver Function | Use cautiously in patients with hepatic impairment |
| Pregnancy | Contraindicated; may cause fetal harm |
| Heart Rhythm | Monitor in patients with QT prolongation risk |
| Infection Risk | Increased susceptibility due to immunosuppression |
🔍 Potential Side Effects
Some side effects may occur during treatment:
- Hematological:
Neutropenia, anemia, thrombocytopenia - General:
Fatigue, weakness, or fever - Hair Loss:
Temporary alopecia - Gastrointestinal:
Nausea, constipation, or decreased appetite - Neurological:
Peripheral neuropathy (tingling or numbness in hands and feet)
Note: Seek immediate medical attention if you experience high fever, severe infection, or persistent adverse effects.
📦 Storage Instructions
- Store at controlled room temperature (20°C–25°C) or as per label instructions
- Protect from light
- Do not freeze
- Keep out of reach of children
- Preparation and handling should be performed by trained medical personnel
⚠️ Medical Disclaimer
Halaven 0.44 mg/ml Injection is a prescription-only chemotherapy medication used for metastatic breast cancer and certain soft tissue sarcomas. The information provided here is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Always consult a qualified oncologist or healthcare professional before starting or modifying any medication.
🌐 Why Buy from Aksharlifescience.com?
- 💊 Authentic, high-quality pharmaceutical products
- 🚀 Fast & trackable shipping (USA & worldwide)
- 🌍 Trusted global pharmaceutical exporter
- 🔐 Secure and discreet packaging
- 🩺 Professional support for prescription-related queries
✅ Order Halaven (0.44 mg/ml) Injection Today
Access advanced cancer treatment with Halaven Injection (Eribulin Mesylate), trusted globally for managing metastatic breast cancer and selected soft tissue sarcomas after prior therapies. Ensure quality care and genuine medicines with a reliable supplier.
Akshar Lifescience – Your Reliable Partner in Global Healthcare.











There are no reviews yet.